Facing the reality of drug-resistant tuberculosis in India : challenges and potential solutions : summary of a joint workshop /

"An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Indian National Science Academy, Indian Council of Medical Research
Otros Autores: Olson, Steve, 1956-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2012.
Temas:
Multidrug-resistant tuberculosis > India > Prevention > Congresses.
Tuberculosis > India > Congresses.
Drug resistance > Congresses.
Multidrug-resistant tuberculosis.
Antitubercular agents.
Tuberculosis.
Tuberculosis, Multidrug-Resistant
Antitubercular Agents
Tuberculosis
Tuberculose > Inde > Congrès.
Résistance aux médicaments > Congrès.
Tuberculose multirésistante.
Antituberculeux.
Tuberculose.
MEDICAL > Oncology.
Multidrug-resistant tuberculosis
Antitubercular agents
Drug resistance
India
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • FrontMatter
  • Reviewers
  • Contents
  • Tables, Figures, and Boxes
  • Acronyms
  • 1 Introduction
  • 2 Drug-Resistant TB in India
  • 3 The Global Burden of Drug-Resistant TB
  • 4 Preventing Transmission of Drug-Resistant TB
  • 5 Detecting Drug Resistance and Strengthening Laboratory Capacity
  • 6 Addressing TB and Drug-Resistant TB in Vulnerable Populations
  • 7 Combating Drug-Resistant TB Through Publicâ€?Private Collaboration and Innovative Approaches
  • 8 Confronting Challenges to the Supply Chain for Secondâ€?Line Drugs
  • 9 Creating a Blueprint for Action

Ejemplares similares